95.10
+2.00
+(2.15%)
At close: 1:30:32 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
410,891.00
256,970.00
202,013.00
929,670.00
64,769.00
Investing Cash Flow
-1,215,556.00
-855,481.00
-188,115.00
-106,998.00
1,764,134.00
Financing Cash Flow
-223,078.00
-294,731.00
-395,707.00
-506,999.00
-87,495.00
End Cash Position
709,542.00
875,617.00
1,768,859.00
2,150,668.00
1,835,741.00
Capital Expenditure
-1,513.00
-412.00
-3,944.00
-229.00
-608.00
Repurchase of Capital Stock
--
--
--
-133,410.00
-3,842.00
Free Cash Flow
409,378.00
256,558.00
198,069.00
929,441.00
64,161.00
12/31/2020 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6589.TWO EirGenix Inc.
79.80
+1.01%
4743.TWO Oneness Biotech Co., Ltd.
79.70
+1.66%
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
6550.TW Polaris Group
43.40
+0.46%
4174.TWO OBI Pharma, Inc.
56.90
+1.25%
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
6712.TWO Ever Supreme Bio Technology Co., Ltd
175.50
-0.28%